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The relation between gleason score, and nuclear size
and shape factors in prostatic adenocarcinoma*
Aim: The aim of this study was to assess the size and shape characteristics of prostatic
adenocarcinoma cell nuclei using a computer-assisted analysis system, and to compare the results
with the Gleason score.
Materials and Methods: Morphometric nuclear parameters, such as roundness factor, form
ellipse, area, length, and perimeter, were evaluated based on specimen slides of 130 prostatic
adenocarcinoma cases (77% needle biopsies and 23% prostatectomy specimens) using a
computerized image analysis system. Correlation analysis between Gleason score and
morphometric results was performed.
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Results: The Gleason score was correlated with mean nuclear area (r = 0.516, P = 0.01), mean
nuclear length (r = 0.298, P = 0.01), and mean nuclear perimeter (r = 0.303, P = 0.01) for all
specimens. In the needle biopsy group the Gleason score was correlated with mean nuclear area (r
= 0.522, P = 0.01), mean nuclear length (r = 0.398, P = 0.01), and mean nuclear perimeter (r =
0.432, P = 0.01), whereas in the prostatectomy group the Gleason score was correlated only with
mean nuclear area (σ = 0.619, P = 0.01) and mean nuclear roundness factor (σ = −0.425, P = 0.05).
Conclusions: Nuclear size and shape factors, especially mean nuclear area, were concordant with
the Gleason score. Nuclear size and shape assessment may aid in the evaluation of the pathological
status of prostatic adenocarcinoma.
Key Words: Gleason score, nuclear size, nuclear shape, prostatic adenocarcinoma

Prostat adenokarsinomunda gleason skor ile nükleer boyut ve şekil
faktörleri arasındaki ilişki
Amaç: Bu çalışmada, bilgisayar destekli görüntü analiz sistemi kullanılarak prostatik
adenokarsinom hücre nükleuslarının boyut ve şekil özellikleri değerlendirilmiş, sonuçlar olguların
Gleason skorları ile karşılaştırılmıştır.
Yöntem ve Gereç: Görüntü analiz sistemi kullanılarak, 130 (% 77’si iğne biyopsi ve % 23’ü
prostatektomi materyali) prostat adenokarsinomunun histolojik kesitlerinde yuvarlaklık faktörü,
elipslik indeksi, alan, uzunluk ve perimetreyi içeren nükleer morfometrik parametreler
değerlendirilmiştir. Morfometrik sonuçlar ile Gleason skorları arasındaki ilişki korelasyon analizi
ile saptanmıştır.
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Bulgular: Tüm materyaller arasında Gleason skor ile ortalama nükleer alan (r = 0,516, P = 0,01),
ortalama nükleer uzunluk (r = 0,298, P = 0,01) ve ortalama nükleer perimeter (r = 0,303, P = 0,01)
arasında ilişki saptanmıştır. Organ iğne biyopsi grubunda ise Gleason skor ile ortalama nükleer
alan (r = 0,522, P = 0,01), ortalama nükleer uzunluk (r = 0,398, P = 0,01) ve ortalama nükleer
perimeter (r = 0,432, P = 0,01) ilişkili bulunmuştur. Prostatektomi grubunda Gleason skor ile
ortalama nükleer alan (σ = 0,619, P = 0,01) ve ortalama yuvarlaklık faktörü (σ = −0,425, P = 0,05)
arasında ilişki tespit edilmiştir.
Sonuç: Nükleer boyut ve şekil faktörleri, özellikle ortalama nükleer alan Gleason skor ile ilişkili
bulunmuştur. Nükleer boyut ve şekil ölçümü, prostatik adenokarsinomun patolojik durumunun
değerlendirilmesine katkı sağlayabilir.
Anahtar Sözcükler: Gleason skor, nükleer boyut, nükleer şekil, prostatik adenokarsinom
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Introduction
The Gleason grading system is widely used for
grading prostatic adenocarcinoma. This system is
based entirely on the histological pattern of
carcinoma cells in hematoxylin and eosin (H&E)stained prostatic tissue sections (1-3). Problems with
Gleason grading include interobserver and
intraobserver variation, and an imprecise predictive
value (4,5). Morphologic changes in nuclei are
characteristic of cancer cells. In particular, changes
in nuclear size, shape, and the nuclear-tocytoplasmic ratio are common features of cancer (6).
These nuclear alterations can be translated into
quantifiable features with digital image analysis and
a process known as quantitative nuclear
morphometry. Image analysis permits pathologists
to obtain quantitative measurements of cytological
and histological preparations, as visual impressions
can be augmented by quantitative morphometry.
This procedure also facilitates exact measurement of
cell size, shape, and organization, which is not
possible with other methods (7). Nuclear size and
shape variation are important prognostic indicators
in breast carcinoma, renal cell carcinoma, and
colorectal adenocarcinoma (8-10). In an effort to
develop an objective method for grading and
predicting the prognosis of prostate cancer, many
investigators
have
used
morphometric
characteristics, such as nuclear area, roundness,
ellipticity, length, perimeter, and volume (7,11-14).
In the present study we investigated the relationship
between Gleason score and nuclear morphometric
features in 130 prostatic adenocarcinomas, based on
needle biopsies and prostatectomy specimens, and
evaluated the diagnostic effects of these
characteristics.
Materials and Methods
Pathological Examination
This study included 130 cases that were
diagnosed with prostatic adenocarcinoma at the
Karaelmas University, Faculty of Medicine,
Department of Pathology between 2001 and 2006.
One hundred of the samples studied (77%) were
prostate needle biopsies and 30 (23%) were radical
prostatectomy specimens. Clinical features of the
382
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cases were obtained from hospital records. All
histological samples were fixed in formalin,
embedded in paraffin, cut into 5-μm sections, and
stained with H&E. All specimen slides were rescored
according to the Gleason system by one pathologist
(S.B.) that was blinded to the previous scores.
Nuclear Morphometry
Morphometric analysis was performed with
H&E-stained histological sections by one
pathologist (S.B.). A microscope (Leica, DMLB100S) was connected to a video camera (Leica, DFC280) and computer. After transferring microscopic
images to the computer, morphometric parameters
were automatically measured by an image analysis
program (Leica, QWINPlus v.3.1.0). About 150
nuclei with sharply demarcated contours were
included in the morphometric analysis of each case.
Nuclei that were markedly distorted during
preparation and those that were significantly
overlapped were excluded from analysis. The
nuclear morphometric parameters studied were as
follows: mean nuclear area (MNA), mean nuclear
perimeter (MNP), mean nuclear length (MNL),
mean nuclear roundness factor (MNRF), and mean
nuclear form ellipse (MNFe). Nuclear roundness
factor was given by the equation: perimeter2/4π ×
area. Nuclear form ellipse was given by the equation:
longest diameter/shortest diameter. These shape
descriptors yielded a minimal value of 1.00 for a
perfect circle and increased as the shape of a contour
deviated from circularity. Nuclear area was the area
enclosed inside the contour, perimeter was the
contour perimeter, and length was the longest
orthogonal projection. All measurements were
made with the 400x objective and were expressed in
micrometers. In all, 130 prostatic adenocarcinoma
cases were evaluated for MNA, MNP, MNL, MNRF,
and MNFe, and the results were compared with the
Gleason score.
Statistical Analysis
Statistical analysis of the measurements was
performed using SPSS v.11 for Windows. The
association between Gleason score and the
morphometric variables was analyzed using
Pearson’s and Spearman’s correlation coefficients.
Before beginning the study, a priori power analysis
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was performed to determine the necessary sample
size for the prostatectomy group. A priori power
analysis indicated that 30 patients would be
sufficient to detect a moderate correlation with a
power greater than 75% at a level of significance of P
< 0.05.
Results
Patient age ranged from 46 to 94 years (mean:
67.23 ± 8.26 years). Distribution of Gleason scores
was as follows: 4 in 1 case (0.7%), 5 in 11 cases
(8.4%), 6 in 42 cases (32.3%), 7 in 58 cases (44.6%),
8 in 9 cases (6.9%), 9 in 8 cases (6.1%), and 10 in 1
case (0.7%). Morphometric nuclear parameters were
as follows: MNA ranged from 12.14 to 51.93 μm2
(mean: 22.43 ± 7.43 μm2), MNP ranged from 13.32
to 28.48 μm (mean: 18.73 ± 3.15 μm), MNL ranged
from 4.64 to 10.27 μm (mean: 6.59 ± 1.07 μm),
MNRF ranged from 1.09 to 1.38 (mean: 1.20 ± 0.06),
and MNFe ranged from 1.27 to 1.8 (mean: 1.50 ±
0.11). Mean number of cancer fields measured was
4.2 for entire study population, 4.1 for the needle
biopsy group, and 4.6 for the prostatectomy group.
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The Table summarizes the clinicopathological
features and nuclear morphometric results of the
needle biopsy and prostatectomy groups.
There were no correlations between age, and
Gleason score and nuclear morphometric
parameters. Among the specimens, Gleason score
was significantly correlated with MNA (r =
0.516, P = 0.01), MNL (r = 0.298, P = 0.01), and
MNP (r = 0.303, P = 0.01), whereas it was not
correlated with MNRF or MNFe (Figure 1). In the
needle biopsy group Gleason score was
significantly correlated with MNA (r = 0.522,
P = 0.01), MNL (r = 0.398, P = 0.01), and
MNP (r = 0.432, P = 0.01), and negatively
correlated with MNFe (r = −0.213, P = 0.05). The
correlation between Gleason score and MNRF was
statistically insignificant (Figure 2). In the
prostatectomy group Gleason score was
positively correlated with MNA (σ = 0.619, P
= 0.01) and negatively correlated with
MNRF (σ = −0.425, P = 0.05). The correlations
between Gleason score, and MNP, MNL, and
MNFe were not statistically significant in the
prostatectomy group (Figure 3).

Table. Clinicopathological and nuclear morphometric features of the needle biopsy and
prostatectomy groups.

Age
Range (mean ± SD)
2
MNA (μm )
Range (mean ± SD)
MNP (μm)
Rang (mean ± SD)
MNL (μm)
Range (mean ± SD)
MNRF
Range (mean ± SD)
MNFe
Range (mean ± SD)
Gleason Score: 4
Gleason Score: 5
Gleason Score: 6
Gleason Score: 7
Gleason Score: 8
Gleason Score: 9
Gleason Score: 10

Needle Biopsy Group
(n = 100)

Prostatectomy Group
(n = 30)

46-94 (68.42 ± 8.42)

53-78 (63.3 ± 6.34)

12.14-49.51 (22.06 ± 7.13)

13.87-51.93 (23.66 ± 8.36)

13.32-28.45 (18.43 ± 3.07)

15.76-28.48 (19.77 ± 3.25)

4.64-10.07 (6.54 ± 1.07)

5.41-10.27 (6.75 ± 1.06)

1.10-1.38 (1.21 ± 0.05)

1.09-1.31 (1.18 ± 0.06)

1.10-1.38 (1.21 ± 0.05)
n = 1 (1%)
n = 7 (7%)
n = 32 (32%)
n = 44 (44%)
n = 9 (9%)
n = 6 (6%)
n = 1 (1%)

1.09-1.31 (1.18 ± 0.06)
n = 4 (13.3%)
n = 10 (33.3%)
n = 14 (46.7%)
n = 2 (6.7%)
-

MNA: Mean nuclear area; MNP: mean nuclear perimeter; MNL: mean nuclear length; MNRF: mean
nuclear roundness factor; MNFe: mean nuclear form ellipse.
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Figure 1. Relationships between Gleason score and nuclear
morphometric parameters in the total study population.
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Figure 2. Relationships between Gleason score and nuclear
morphometric parameters in the needle biopsy group.
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The Gleason grading system is widely used to
determine the degree of malignancy of prostatic
cancer and to predict the prognosis (1-3,15);
however, it is difficult to reproduce identical results
among pathologists because of the subjective nature
of the system (4,5,16). In recent years many methods
have been studied in an effort to overcome the
subjectivity of the conventional histologic grading
system, one of which is quantitative measurement of
the pathological features of tumor cells. The
potential advantages of morphometric analysis in
histopathology are its objectiveness, accuracy, and
efficiency (17,18). There are many different
mathematically derived nuclear morphometric
descriptors of H&E-stained tissue sections that can
be quantitatively calculated using image analysis
systems. The initial results of nuclear morphometry
reported in 1982 by Diamond et al. showed that
nuclear roundness accurately identified 27 patients
with stage B1 or B2 prostate cancer that were treated
surgically (19). Similarly, Partin et al., Mohler et al.,
Hurwitz et al., and Martinez-Jabaloyas et al.
reported a very good correlation between prognosis,
and the nuclear roundness factor and nuclear form
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Figure 3. Relationships between Gleason score and nuclear
morphometric parameters in the prostatectomy group.
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ellipse (18,20,21,23); however, Blom et al. did not
observe any correlation between prognosis and these
nuclear shape descriptors (22). In the present study
Gleason score was negatively correlated with MNFe
in the needle biopsy group. We also observed that
Gleason score was negatively correlated with MNRF
in the prostatectomy group; however, Gleason score
was not correlated with MNRF or MNFe in the total
study population. It has been reported that nuclei in
benign prostate hyperplasias have less nuclear area
and greater mean nuclear form ellipse than nuclei in
prostate adenocarcinomas. In addition, it has been
shown that mean nuclear area has prognostic value
and correlates with Gleason score (23-25). Published
data suggest that mean nuclear area greater than 28
μm2 and mean nuclear diameter greater than 5 μm
predict malignancy. In the present study MNA and
MNL ranged from 12.14 to 51.93 μm2 (mean: 22.43)
and 4.64 to 10.27 μm (mean: 6.59), respectively. In
contrast to previous studies, we detected lower
MNA values (26.27). Possible explanations for these
discrepant results are compression artifacts during
needle biopsy and artifacts due to delayed fixation of
prostatectomy specimens.
Our results demonstrate that Gleason score was
significantly correlated only with MNA in both the
needle biopsy and prostatectomy groups, and in the
total study population; however, MNRF showed
significant concordance with Gleason score only in
the prostatectomy group. Needle biopsy is a routine
diagnostic procedure for patients with prostate
cancer. It is expected to provide useful pathologic
information that can aid in treatment decisions and
in predicting cancer progression. Therefore, the
correlation between MNA and Gleason score,
particularly in the needle biopsy and prostatectomy
specimens observed in the present study, indicates
that MNA may provide additional assistance in
evaluating the pathologic status and prognosis of the
disease, and contribute to preoperative treatment.
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Nuclear morphometric characteristics provided
improved prediction of outcome when compared
with standard predictive tools. Moreover, recent
data indicate that nuclear morphometry, with or
without clinical and histopathologic parameters,
may be beneficial in predicting recurrence and
prognosis of prostatic adenocarcinoma (14,28-30).
Technical considerations limiting the use of
nuclear morphometry are mainly associated with
cost and reproducibility. Mohler et al. measured the
accuracy and reproducibility of such a system for
nuclear morphometry measurements, and reported
a reproducibility and accuracy of greater than 95%
when studying standard microscopic shapes (17,18).
Quantitative
assessment
of
nuclear
morphometry is possible with computer imaging
systems, providing a useful and reproducible
method of predicting the prognosis of many cancers.
Nuclear morphometric parameters have been
compared with conventional grading systems for
malignancy of various organs (8-10). Many studies
have demonstrated that a computer-based nuclear
morphometry system can add to the prognostic
information provided by the Gleason scoring system
(21,23,24,31). Additionally, the World Health
Organization recommended the use of nuclear
morphometry in prostate cancer (32). In the present
study nuclear size and shape factors were
concordant with Gleason score in both the needle
biopsy and prostatectomy groups. Nuclear size and
shape assessment, especially MNA, may support the
evaluation of the pathological status of prostatic
adenocarcinoma.
To summarize, nuclear morphometry may be
used as a diagnostic tool to supplement the Gleason
grade in prostatic adenocarcinoma. Considering its
exact and objective measurement of cell size and
shape, morphometric analysis might help improve
our understanding of the diagnostic and prognostic
features of prostatic adenocarcinoma.
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